Actively Recruiting
Smartphone Blood Pressure Measurement to Screen for Hypertension
Led by Centre Hospitalier Universitaire Vaudois · Updated on 2026-03-27
100
Participants Needed
2
Research Sites
121 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this observational study is to assess the feasibility of classifying people whose blood pressures are within hypertensive range using a machine-learning approach based on features derived from smartphone video data recorded at the patient's fingertips. The main question\[s\] it aims to answer are: Is a smartphone a reliable device for high blood pressure screening ? Is a smartphone a reliable device for blood pressure monitoring ? Participants will record their blood pressure with a smartphone at their fingertips and with an approved cuff device, 3 times in the morning and 3 times in the evening for 7 days. There will be two groups, a volunteer presumed healthy, and a volunteer addressed for a Home Blood pressure monitoring with the diagnosis of hypertension suspected. Researchers will compare the two groups to see if the smartphone can be reliable in terms of diagnosis and monitoring of the blood pressure comparing to a standard cuff device.
CONDITIONS
Official Title
Smartphone Blood Pressure Measurement to Screen for Hypertension
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Informed consent as documented by signature
- Men or women older than 18 years old
- Good understanding of written and oral speaking used at the center where the study will be carried out
You will not qualify if you...
- Patients that cannot sign informed consent
- Patients in emergency situation, are not legally competent, cannot understand the situation or are vulnerable
- Unable to participate due to pain or stress [12]
- Known or suspected non-compliance (e.g. drug or alcohol abuse, language problems, psychological disorders, dementia)
- Patients older than 80 years old [4] [13]
- Known pregnancy
- Known unstable cardiac condition (myocardial infarction < 1 week, decompensated heart failure, pulmonary embolism)
- End-stage renal disease (GFR < 15/min/1.73m2 and/or dialysis) [4] [14] [15] [16]
- Diabetes mellitus [15] [8]
- Known (or assessed by recording heart rate and using pulse palpation, as recommended in ESC/ESH guidelines [1]) cardiac arrhythmia (atrial fibrillation, numerous extrasystoles and important bradycardia/bradyarrhythmia, bigeminy, trigeminy, isolated VPB) [4] [1] [7] [15] [17]
- SBP or DBP difference between two arms >10 mmHg [8] [18]
- Patient with finger lesions that would alter the correct capture of signals by the mobile phone.
- Known mobile phone contact dermatitis (caused by metal allergens, notably nickel and chromium
- Incapacity of properly using the smartphone (i.e. incapacity of obtaining a recording with sufficient signal quality after the dedicated training)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
University Hospital Lausanne
Lausanne, Canton of Vaud, Switzerland, 1011
Actively Recruiting
2
University Hospital Lausanne CHUV
Lausanne, Switzerland, 1011
Actively Recruiting
Research Team
P
Patrick Schoettker, Professor
CONTACT
M
Maxime Merz
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here